AstraZeneca PLC ADR falls Tuesday, underperforms market
The AstraZeneca PLC ADR AZN shed 1.22% to $72.60 Tuesday, on what proved to be an all-around mixed trading session for the ...
AstraZeneca (AZN) Receives a Buy from UBS
In a report released today, Matthew Weston from UBS maintained a Buy rating on AstraZeneca (AZN – Research Report), with a price target of ...
AstraZeneca (AZN) Receives a Buy from J.P. Morgan
J.P. Morgan analyst James Gordon maintained a Buy rating on AstraZeneca (AZN – Research Report) today and set a price target of £140.00. The ...
AstraZeneca rallies Friday, outperforms market
AstraZeneca PLC closed 14.73% below its 52-week high of £133.88, which the company achieved on September 3rd.